India to Canada: Fluoxetine Export Trade Route

The India to Canada Fluoxetine corridor is one of India's established pharmaceutical export routes, with 130 shipments documented worth a combined $30.3M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's fluoxetine manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $233.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 18.5%, placing it at rank #2 among India's top fluoxetine export destinations globally.

On the import side, key buyers of Indian fluoxetine in Canada include ACCORD HEALTHCARE INC,, ACCORD HEALTHCARE INC.,, ACCORD HEALTHCARE INC., and 27 others. ACCORD HEALTHCARE INC, is the single largest importer with 4 shipments valued at $25.4M USD.

India's fluoxetine exports to Canada are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 28 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , ALEMBIC PHARMACEUTICALS LIMITED — together account for 98% of total trade value on this route. The average shipment value of $233.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ph.dru.& med.: prach-fluoxetine 10mg capusles (each hard gelatine capsule contains: fluoxetine 10mg) [1x100c per pack] and pharma drugs and medi jamp-fluoxetine capsules 20mg as per inv, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE INC, is the largest importer with 4 shipments worth $25.4M USD — representing 84% of all fluoxetine imports from India on this route. A total of 30 buyers are active on this corridor.